Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial. Groupe Régional d'Etude du Cancer Colo-Rectal (Belgium). [electronic resource]
Producer: 20010222Description: 549-54 p. digitalISSN:- 0959-4973
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chemotherapy, Adjuvant
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Mitomycin -- administration & dosage
- Neoplasm Metastasis
- Neoplasm Recurrence, Local
- Portal Vein
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.